Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial

BACKGROUND: Nonalcoholic steatohepatitis (NASH) is associated with increased cardiovascular risk and mortality. No US Food and Drug Administration (FDA) approved therapies for NASH are available; clinical trials to date have not yet systematically assessed for changes in cardiovascular risk. This st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Therap Adv Gastroenterol
Main Authors: Lin, Steven C., Ang, Brandon, Hernandez, Carolyn, Bettencourt, Ricki, Jain, Rashmi, Salotti, Joanie, Richards, Lisa, Kono, Yuko, Bhatt, Archana, Aryafar, Hamed, Lin, Grace Y., Valasek, Mark A., Sirlin, Claude B., Brouha, Sharon, Loomba, Rohit
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4749859/
https://ncbi.nlm.nih.gov/pubmed/26929777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X15621232
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados